Form 4: Molina Healthcare Director Richard M. Schapiro Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Richard M. Schapiro acquired 189 shares of Molina Healthcare common stock on January 1, 2025, as part of the company's equity incentive plan.
Summary
- Richard M. Schapiro, a director of Molina Healthcare, Inc., reported the acquisition of 189 shares of common stock on January 1, 2025.
- The acquisition was made under the company's 2019 Equity Incentive Plan as compensation for his services as a director.
- The shares were granted at a price of $291.05 per share, based on the closing price of Molina Healthcare's common stock on December 31, 2024.
- Following the transaction, Schapiro directly owns 11,745 shares of Molina Healthcare common stock.
- The filing also includes a Limited Power of Attorney, granting Jeff D. Barlow and Codruta Boggs the authority to execute and file Section 16(a) forms on Schapiro's behalf.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and well-governed company. The sentiment is neutral to slightly positive.
Positives
- The equity grant aligns the director's interests with those of the shareholders.
- The grant is part of a pre-determined compensation plan, providing transparency and predictability.
Industry Context
This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.
Comparison to Industry Standards
- Director compensation packages, including equity grants, are common practice among publicly traded healthcare companies.
- Companies like UnitedHealth Group, Anthem, and Humana also utilize equity incentive plans for their directors.
- The size and structure of the equity grant are generally benchmarked against peer companies to ensure competitiveness and alignment with performance.
Stakeholder Impact
- The equity grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
- The transaction has a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| July 29, 2015 | Date of Limited Power of Attorney execution. |
| December 31, 2024 | Closing price of Molina Healthcare common stock used to calculate the number of shares granted ($291.05). |
| January 1, 2025 | Date of stock acquisition. |
| January 2, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.